ArticleBritish journal of cancer2001

Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.

A Di Paolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.